Skip to content

Global cost of HIV treatment and prevention could reach $35 billion by 2031

International donors must not retreat from commitment to HIV treatment scale-up, MSF warns

Certain manifestations of stigma especially hurtful for people with HIV

GSK and Pfizer launch joint HIV venture, ViiV Healthcare

Lost to care: the mystery of the disappearing patients

Retention in opioid replacement programmes improves chances of HIV treatment working for drug users

Cost-effective ways to reduce loss to follow-up in ART programmes identified

Health care providers must respond to HIV-related stigma

Study rates Luxembourg as having the best HIV prevention and care in Europe